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serotypes 1-7 (AD 1-7) and control RNA were detected by multi-
plex RT-PCR. In second multiplex nested RT-PCR influenza viruses
subtypes A and B were differentiated.
Results: Between 12/04 and 1/08 we analyzed a total of 149 NS
collected from 88 patients and 134 BALF collected from 100 pa-
tients. The following pathogens were identified in NS/BALF, re-
spectively: RSV -26/17, AD (1-7) – 1/1, PIV1 – 2/2, PIV2 – 3/1,
PIV 3 – 4/4, FLU A – 9/5 and FLU B – 1/1. Four patients were si-
multaneously infected with two viruses (2 – RSV and FLU A, 2 – RSV
and PIV3).
Conclusions: Presented multiplex RT-PCR assay enables cheap,
rapid and sensitive detection of many pathogens at the same time,
even when mixed infection is present. Using of the internal con-
trol of RNA isolation and sample inhibition ensures that true and
false-negative results are distinguishable in the assay. Although RV
infections were common in our study (23.1% BALF and 30.8% NS
positive) in most patients just symptomatic treatment was needed.
Thus clinical significance of the virus detection needs further eval-
uation.
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Background: VRE are significant nosocomial pathogens in immuno-
compromised pts with hematological malignancies. Continual mon-
itoring of incidence of VRE and targeted prevention are necessary
for improvement of complex care of hemato-oncological patients.
Objectives and Methods: The aim of the study was the retrospec-
tive analysis of phenotypic and clinical epidemiological trends of
VRE at large hemato-oncological department. in Czech Republic
between 2003-2007. At the same time we analyzed antibiotic (ATB)
consumption in the entire period.
Results: During the 5-year period total No. of all patients with VRE
colonization or infection was 186 (vanA – 155, vanB – 31). Blood
Figure 1. Trends in comsumption of antibiotics in 2000–2007.
Figure 2. Trends in colonization and infection caused by VRE in 2000–2007.
cultures (BC) were positive for VRE in 11 cases. In 2004 an exces-
sive outbreak of VRE isolates occurred, both in colonization and
BC (46 – 2003 vs. 111 – 2004). The percentage ratio of VRE from
all enterococci also increased (10% – 2003 vs. 25% – 2004). The %
ratio of VRE from all enterococci in BC also rose (8% – 2003 vs. 40%
– 2004). We identified these possible reasons: 1) enhanced usage
of vancomycin and the third generation (III.g.) cephalosporins in
2000-2002 (average consumption of ATB in PDD/1000 bed-days –
vancomycin: 63, III.gen. ceph.: 59); 2) lack of regimen. This emer-
gence of VRE was reason for institution of appropriate regimen
(including regular detection and isolation of VRE carriers, hand-
hygiene) and marked restriction in usage of the above mentioned
groups of ATB (2005 - vancomycin: 33, III. gen. ceph.: 15). These
precautions led to the significant decrease of VRE in the following
years (2005 - 16 pts. with VRE colonization or infection, 2% VRE
from all isolates of enterococci, 1 VRE in BC, 3% VRE of all entero-
cocci in BC).
Conclusions: Regular detection of VRE carriers, particular judi-
cious use of vancomycin and III. gen. cephalosporins and institu-
tion of appropriate regimen facilitated significant decrease of VRE
at our dpt. and thus resulted in lower morbidity and mortality and
healthcare costs.
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Background: Early sensitive diagnosis of invasive mycoses (IM) in
pts with persistent febrile neutropenia (PFN) is important for tai-
lored use of antifungals and optimizing successful outcome. We
assessed the clinical usefulness of the beta-D-glucan (BG) assay in
patients with PFN at risk from IM.
Materials and Methods: One hundred adults with haematological
malignancy neutropenic (<500/ml) with persistent fever (>38.3 C
>4days) after chemotherapy had alternate day serum assayed for
BG (Cape Cod Assocs). IM diagnosed as per EORTC/MSG criteria. No
pt had antifungal drug prophylaxis. Pts with PFN unresponsive to
antibiotics received empirical treatment with 3mg (increasing to
5-10 for IM) per kg/day liposomal amphotericin B. The mean and
median BG concentrations in the two pt subgroups of PFN alone or
with IM were compared with the Mann-Whitney test. 2x2 contin-
gency tables were analysed with Fisher' s exact test.
Results: IM developed in 38 (14 candidiasis [12 proven/probable,
2 possible], 24 aspergillosis [14 probable, 10 possible], PFN only
in 42 pts. Serum BG was significantly elevated on the first day of
PFN and all subsequent days to day 10 PFN in pts who developed
IM (Figure 1). Median BG was 95.8 and 32.9 pg/ml for patients with
IM and only PFN respectively (p<0.0001). Antifungal therapy did
not affect the values over the first 10 days. There was consider-
able inter-patient variability in BG time-patterns. Using cut-offs of
between 60 and 100 pg/ml, at least 2 sequential values >80 pg/ml
(' positive test' ) gave optimal accuracy of 81%, positive/negative
predictive values respectively of 77/87%. Of pts with IM 78% had
a positive test a mean of 1.25 days prior to IM diagnosis. However
by sampling from the first neutropenic day instead of from PFN,
50% of those with IM were detected 5 days earlier. Daily sampling
did not improve the sensitivity. 73% of pts with at least 2 readings
but without IM had severe mucositis/enterocolitis compared with
19% who had less than 2 readings at least 80 pg/ml (p=0.002). In
most cases the rises in BG were transient (Figure 2). The overall
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usefulness in guiding initial antifungal therapy was approximately
70%.
Conclusion: Alternate day determination of BG concentrations in
pts with PFN is a useful adjunct in identifying those who develop
IM, when used as part of an overall clinical and radiological evalu-
ation strategy. Pts with transient elevation of BG usually had ente-
rocolitis and thus may have low-burden fungemia of gut origin.
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Background: Anaemia is one of the most dreaded complications
among patients with malignant pathologies. Its causes can be var-
ied and whatever its severity, the impact on the quality of life of
the patient remains essential. Despite this complication in cancer
patients, limited studies have been conducted in this field and so
research data in the literature concerning anaemia are very lim-
ited. This study was therefore conducted to determine the preva-
lence and the management of anaemia amongst patients with ma-
lignant diseases.
Methods: A national survey was conducted between February 2006
and March 2007. This observational multicentric study was con-
ducted with 150 experts practicing in all the major health institu-
tions or units treating patients with solid tumours and/or malignant
haematological diseases in Cameroon. Control over one day stan-
dard of consultation for each questioned expert, 534 patients were
enrolled, including 335 (62.7%) patient with solid tumour and 199
(37.3%) patient with malignant haematological disease.
Results: The median age was 48 years (range: 11- 82 years) includ-
ing 162 men (30%) and 372 women (70%). At enrollment, the me-
dian level of haemoglobin (Hb) was 10.3 g/dl (range: 4.7-17.3 g/dl)
and 38% of patient had a level of Hb < 11 g/dl. Anaemia was found
in all the cancer localizations and whatever the stage or the ther-
apeutic status of the disease. About 3/4 of the anaemic patients
received treatment by erythropoiesis stimulating agent (ESA) and
approximately 24% of them did not receive any specific treatment
for the anaemia. The median level of Hb at the introduction of the
ESA was 9.2 g/dl.
Conclusion: Our results show an improvement in the management
of anaemia and the use of the ESA in patients with various cancers.
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Objective: Identification and susceptibility tests on strains iso-
lated from blood samples of patients hospitalized in Department
of Haematology in 2007.
Materials and Methods: From January to the end of December 2007
in Mycology Laboratory the 427 positive mycological cultures from
clinical samples of patients hospitalized in Department of Haema-
tology were identified. Fifteen (3,5%) of all specimens were the
blood positive samples. The clinical material was examined accord-
ing to the standard mycological procedures. The isolated strains
were incubated on Sabouraud medium plates with addition of gen-
tamicin and chloramphenicol (Becton Dickinson). The identifica-
tion of the isolates was performed on CHROMagar Candida medium
and automatic test of ID32 C (bioMerieux). The susceptibility tests
for antifungal agents: Amphotericin B, Itraconazole, Fluconazole,
Voriconazole, Caspofungin and Posaconazole, was done using E-
tests (AB Biodisk).
Results: From the whole number of 427 samples from Department
of Haematology, the positive blood samples were 3.5% - 15. The
